BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Mar 22, 2010
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Azur Pharma, Elan sales and marketing update

Azur acquired worldwide, ex-European rights to Prialt ziconotide intrathecal infusion from Elan's Elan Pharmaceuticals Inc. subsidiary for an undisclosed sum. The N-type calcium channel blocker...

Read the full 123 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >